In other Supernus Pharmaceuticals news, SVP Jonathan Rubin sold 927 shares of the firm’s stock in a transaction that occurred on Friday, February 21st. The shares were sold at an average price ...

Supernus Pharmaceuticals (NASDAQ ... which is available through the SEC website. Also, SVP Jonathan Rubin sold 927 shares of the business’s stock in a transaction dated Friday, February 21st ...

Supernus Pharmaceutical’s stock declined following ... In an October 2024 conference call, Supernus’s CMO Jonathan Rubin said the company would decide which indication to pursue further ...

The Phase IIb study enrolled 250 adult patients with treatment-resistant depression. Credit: Justin Paget via Getty Images. Supernus Pharmaceutical’s stock declined following the release of ...

Today, we are looking at branded pharmaceuticals stocks, starting with Supernus Pharmaceuticals (NASDAQ:SUPN). The branded pharmaceutical industry relies on a high-cost, high-reward business model ...